Correlation Between Reviva Pharmaceuticals and Quoin Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and Quoin Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and Quoin Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and Quoin Pharmaceuticals Ltd, you can compare the effects of market volatilities on Reviva Pharmaceuticals and Quoin Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of Quoin Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and Quoin Pharmaceuticals.

Diversification Opportunities for Reviva Pharmaceuticals and Quoin Pharmaceuticals

0.19
  Correlation Coefficient

Average diversification

The 3 months correlation between Reviva and Quoin is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and Quoin Pharmaceuticals Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quoin Pharmaceuticals and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with Quoin Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quoin Pharmaceuticals has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and Quoin Pharmaceuticals go up and down completely randomly.

Pair Corralation between Reviva Pharmaceuticals and Quoin Pharmaceuticals

Given the investment horizon of 90 days Reviva Pharmaceuticals Holdings is expected to generate 0.82 times more return on investment than Quoin Pharmaceuticals. However, Reviva Pharmaceuticals Holdings is 1.21 times less risky than Quoin Pharmaceuticals. It trades about 0.19 of its potential returns per unit of risk. Quoin Pharmaceuticals Ltd is currently generating about 0.06 per unit of risk. If you would invest  117.00  in Reviva Pharmaceuticals Holdings on September 14, 2024 and sell it today you would earn a total of  150.00  from holding Reviva Pharmaceuticals Holdings or generate 128.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Reviva Pharmaceuticals Holding  vs.  Quoin Pharmaceuticals Ltd

 Performance 
       Timeline  
Reviva Pharmaceuticals 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Reviva Pharmaceuticals Holdings are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Reviva Pharmaceuticals demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Quoin Pharmaceuticals 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Quoin Pharmaceuticals Ltd are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Quoin Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Reviva Pharmaceuticals and Quoin Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Reviva Pharmaceuticals and Quoin Pharmaceuticals

The main advantage of trading using opposite Reviva Pharmaceuticals and Quoin Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, Quoin Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quoin Pharmaceuticals will offset losses from the drop in Quoin Pharmaceuticals' long position.
The idea behind Reviva Pharmaceuticals Holdings and Quoin Pharmaceuticals Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated